drugset / Trial / NCT03794973
Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)
RandomizedParallel-groupTriple-blindTreatment
Summary
The study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial in subjects with new onset T1D.
Timeline
- Start
- 2019-12-14
- Primary completion
- 2021-12-14
- Completion
- 2023-12-14
Outcome
Outcome not reported
Stopped: “Modification to Clinical Development Plan”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TOL-3021 | Other / unclassified | 1 mg | — |
| Subject | TOL-3021 | Other / unclassified | 2 mg/ml | — |